Immunotherapy: Balancing Cancer Treatment Benefits and Risks

Immunotherapy: Balancing Cancer Treatment Benefits and Risks

As immunotherapy has emerged as the fourth pillar of cancer treatment — alongside surgery, radiation, and chemotherapy — Yale researchers are scrutinizing its toxicities and investigating ways to minimize risks and amplify benefits.

When a person develops tumors s litos no est mago, it is done or difficult, the oncologists know how to treat them. But often the cures v m have serious effects on the quality of life. This may include the removal of the oest mago or bexiga, a permanent colostomy bag, radiation that makes patients inf rteis and lasting damage to chemotherapy. Read more (05/02/2025

Immunotherapy Removes Surgery Need in dMMR Cancers: AACR 2025

At AACR 2025, researchers presented breakthrough data showing that neoadjuvant PD-1 blockade in early-stage dMMR cancers led to complete tumor response in most patients, allowing many to avoid surgery altogether.